Buy Sprycel Online

Sprycel is a cancer medicine containing dasatinib, a tyrosine kinase inhibitor used for certain Philadelphia chromosome-positive leukemias. It can be ordered with the strength and quantity that match your clinician’s directions, with current Sprycel price information shown during checkout. BorderFreeHealth offers cash-pay access with US delivery from Canada for customers managing out-of-pocket treatment costs.

Sprycel Price, Strengths, and Ordering Basics

Sprycel cost can vary by tablet strength, quantity, and current supply. During ordering, choose the dose strength shown for Sprycel and make sure it matches the directions from your oncology team. Common tablet strengths include 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, including the Sprycel 100 mg tablet, Sprycel 70 mg tablet, and higher-strength tablets used in specific treatment plans.

Many people look at Sprycel cash price, Sprycel out of pocket cost, or Sprycel cost without insurance because oncology medicines can be expensive. Canadian pricing may help you understand self-pay choices before you proceed. Final amounts depend on the tablet strength, quantity, and the product selected at checkout; do not change your strength or schedule to reduce cost unless your clinician gives you new instructions.

Quick tip: Keep the written strength, dosing schedule, and quantity from your care team nearby when placing an order.

What Sprycel Treats

Sprycel is used for Philadelphia chromosome-positive chronic myeloid leukemia, often shortened to Ph-positive CML. Chronic myeloid leukemia is a blood and bone marrow cancer linked to an abnormal BCR-ABL protein that sends growth signals to leukemia cells. For more condition background, see chronic myeloid leukemia.

Sprycel also has labeled uses in Philadelphia chromosome-positive acute lymphoblastic leukemia, called Ph-positive ALL, in specific treatment settings. ALL is a faster-growing leukemia, and treatment choices depend on age, prior therapy, response history, blood counts, and other clinical findings. You can read more about this related diagnosis under Philadelphia chromosome-positive acute lymphoblastic leukemia.

Your clinician decides whether dasatinib fits your diagnosis and treatment stage. Sprycel may be used in newly diagnosed chronic-phase Ph-positive CML or after intolerance or resistance to earlier therapy, depending on the labeled indication and your individual disease profile.

How Dasatinib Works

Sprycel contains dasatinib, a tyrosine kinase inhibitor. Tyrosine kinases are enzymes that help cells send growth and survival signals. Dasatinib blocks BCR-ABL and other kinases involved in leukemia cell growth, which may slow or stop the abnormal signaling that drives certain leukemias.

This mechanism makes Sprycel part of the targeted therapy group rather than traditional chemotherapy. Targeted medicines still require careful monitoring because they can affect healthy cells and body systems. For a deeper explanation of the active ingredient, see dasatinib mechanism of action.

Response is usually assessed through laboratory testing rather than how you feel day to day. Your oncology team may follow complete blood counts, chemistry panels, and BCR-ABL test results to evaluate safety and treatment response over time.

How to Take Sprycel Tablets

Sprycel tablets are typically taken once daily, but your exact schedule comes from your clinician. Swallow tablets whole with water. Do not crush, split, or chew them, because tablet handling can affect exposure and may create unnecessary contact with the medicine.

Sprycel may be taken with or without food. Grapefruit and grapefruit juice should be avoided because they can change how your body processes dasatinib. Try to take the tablet at the same time each day so the medicine becomes part of a steady routine.

Acid-reducing medicines need special attention. Antacids may need to be separated from Sprycel by several hours, while proton pump inhibitors and H2 blockers may reduce dasatinib exposure and are often avoided or replaced with a different plan. Share your complete medication list, including over-the-counter products and supplements, before starting or refilling therapy.

Missed Dose, Vomiting, and Timing Questions

If you miss a dose, follow your clinician’s instructions or the official label guidance. In general, people are told not to take two doses at the same time to make up for a missed tablet. If it is close to your next scheduled dose, ask your care team how they want you to handle future missed doses.

If vomiting happens after a dose, do not automatically take an extra tablet unless your clinician has specifically told you to do so. Repeated vomiting, diarrhea, or inability to keep tablets down can affect treatment consistency and should be reported promptly.

Set refill and daily-dose reminders before you run low. Consistency matters with tyrosine kinase inhibitor therapy, and missed tablets can interfere with the treatment plan your clinician is tracking through blood tests.

Storage, Handling, and Travel

Store Sprycel tablets at room temperature in the original container, away from excess moisture and light. Keep the bottle tightly closed and out of reach of children and pets. Do not use tablets that are expired, broken, or damaged.

When traveling, keep Sprycel in hand luggage with the labeled container and a copy of your medication list. Avoid leaving tablets in a hot car, checked baggage exposed to temperature swings, or damp areas such as bathrooms. If you need a refill around travel dates, order early enough to avoid gaps in treatment; orders may be sent with prompt, express shipping.

Caregivers should avoid unnecessary contact with crushed or broken tablets. If a tablet is damaged, ask a pharmacist or clinician how to dispose of it safely rather than attempting to repair or split it.

Side Effects, Warnings, and Monitoring

Common Sprycel side effects can include headache, diarrhea, nausea, fatigue, rash, muscle pain, joint pain, abdominal discomfort, and swelling from fluid retention. Some effects are mild and manageable, but new or worsening symptoms should be reported because oncology treatment plans often depend on early safety checks.

Serious risks include low blood cell counts, significant bleeding, pleural effusion, pulmonary arterial hypertension, heart rhythm changes including QT prolongation, liver problems, and severe fluid retention. Seek urgent help for chest pain, sudden shortness of breath, fainting, severe dizziness, signs of major bleeding, or symptoms of a serious allergic reaction.

Monitoring may include complete blood counts, liver tests, electrolyte checks, BCR-ABL response testing, and sometimes an electrocardiogram or chest imaging. People with a history of major bleeding, heart rhythm problems, pulmonary arterial hypertension, liver disease, or low blood counts need individualized review before and during treatment.

Sprycel may harm an unborn baby. People who are pregnant, planning pregnancy, or able to become pregnant should discuss contraception and pregnancy testing with their clinician. Breastfeeding is not recommended during treatment and for a period after the last dose according to labeling.

Important Drug Interactions

Dasatinib is affected by CYP3A4, an enzyme involved in drug metabolism. Strong CYP3A4 inhibitors such as ketoconazole or clarithromycin can increase dasatinib levels and may raise side effect risk. Strong CYP3A4 inducers such as rifampin, some seizure medicines, and St. John’s wort can lower exposure and may reduce effectiveness.

Blood thinners, antiplatelet medicines, and drugs that affect clotting may increase bleeding risk when used with Sprycel. Acid-reducing therapies can also be important because stomach acidity affects dasatinib absorption. Bring all medicines, vitamins, herbal products, and occasional over-the-counter treatments to each medication review.

Why it matters: Interaction checks help protect both treatment effect and safety, especially when new medicines are added between oncology visits.

Sprycel, Dasatinib, and Related Treatment Choices

Sprycel is the brand name for dasatinib. Depending on what is available and appropriate for your treatment plan, your clinician may discuss dasatinib tablets or other tyrosine kinase inhibitors. If dasatinib is specifically part of your plan, dasatinib tablets may be a related product to discuss with your care team.

Other medicines in the broader CML treatment class include different tyrosine kinase inhibitors with separate dosing, safety, and interaction profiles. Your clinician may consider prior response, mutation testing, heart and blood-vessel risks, fluid retention history, and tolerance when choosing among therapies. For broader oncology browsing, see the cancer medicines category.

Nilotinib is another targeted therapy sometimes used in Ph-positive CML. Its prescribing considerations differ from dasatinib, including food timing and cardiac safety issues. For context on that medicine’s label and dosing themes, see Tasigna prescribing information and dosage.

What to Ask Your Clinician Before Refilling

• Which Sprycel strength should I continue taking?
• How often will my blood counts and BCR-ABL levels be checked?
• What symptoms of fluid buildup or bleeding require urgent care?
• Can I take antacids, heartburn medicines, or supplements with this therapy?
• Should any medicines be changed because of CYP3A4 interactions?
• What should I do if I miss a dose or vomit after taking a tablet?
• How should we plan refills around travel, lab appointments, or dose changes?

Authoritative Sources

Sprycel can be ordered in the strength and quantity that align with your clinician’s treatment directions. Use the current checkout information to view Sprycel price details, select the needed tablet strength, and plan refills before your existing supply runs low.

This content is for informational purposes only and is not a substitute for professional medical advice.